[Federal Register Volume 76, Number 213 (Thursday, November 3, 2011)]
[Notices]
[Pages 68192-68193]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-28489]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


 Meeting of the Advisory Committee on Blood Safety and 
Availability

AGENCY: Department of Health and Human Services, Office of the 
Secretary, Office of the Assistant Secretary for Health.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: As stipulated by the Federal Advisory Committee Act, the U.S. 
Department of Health and Human Services is hereby giving notice that 
the Advisory Committee on Blood Safety and Availability (ACBSA) will 
hold a meeting. The meeting will be open to the public.

DATES: The meeting will take place Monday, December 5, and Tuesday 
December 6, 2011, from 9 a.m. to 5 p.m.

ADDRESSES: National Institutes of Health Conference Room, 5635 Fishers 
Lane, Terrace Level, Rockville, MD 20852.

[[Page 68193]]


FOR FURTHER INFORMATION CONTACT: Mr. James Berger, Acting Executive 
Secretary, ACBSA, Office of the Assistant Secretary for Health, 
Department of Health and Human Services, 1101 Wootton Parkway, Suite 
250, Rockville, MD 20852, (240) 453-8809, FAX (240) 453-8456, email 
[email protected].

SUPPLEMENTARY INFORMATION: The ACBSA provides advice to the Secretary, 
through the Assistant Secretary for Health, on a broad range of issues 
involving the safety and availability of blood and blood products. The 
agenda for the meeting includes discussion by the Committee on the 
current informed consent laws for blood, organ, cells, and tissues. The 
Committee will examine the informed consent laws and consider making 
recommendations about legal reform. In keeping with established 
mission, the ACBSA also will be asked to review and comment on previous 
ACBSA recommendations.
    The public will have the opportunity to present their views to the 
Committee during a public comment session scheduled for December 6, 
2011. Comments will be limited to five minutes per speaker and must be 
pertinent to the discussion. Pre-registration is required for 
participation in the public comment session. Any member of the public 
who would like to participate in this session is encouraged to contact 
the Acting Executive Secretary at his/her earliest convenience to 
register for time (limited to 5 minutes) and registration must be prior 
to close of business on December 1, 2011. If it is not possible to 
provide 30 copies of the material to be distributed, then individuals 
are requested to provide a minimum of one (1) copy of the document(s) 
to the Acting Executive Secretary to be distributed prior to the close 
of business on December 5, 2011. It is also requested that any member 
of the public who wishes to provide comments to the Committee utilizing 
electronic data projection to submit the necessary material to the 
Acting Executive Secretary prior to the close of business on December 
1, 2011. Electronic comments must adhere to disability accessibility 
guidelines (Section 508 compliance).

    Dated: October 27, 2011.
James J. Berger,
Acting Executive Secretary, Advisory Committee on Blood Safety and 
Availability.
[FR Doc. 2011-28489 Filed 11-2-11; 8:45 am]
BILLING CODE 4150-41-P